Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 57967 82 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110002989B reveals a high-selectivity synthesis for 5-bromo-2-chlorobenzoic acid, offering cost reduction and superior purity for SGLT-2 inhibitor manufacturing.